#Sweden #Dividend #Stockholm #Stock Market #RaySearch Laboratories

RaySearch Laboratories' Dividend Update

On February 21, 2025, RaySearch Laboratories AB (publ) revealed an important adjustment regarding its planned dividend for the fiscal year of 2024. The Board has proposed a dividend payout of 3.00 SEK per share, which is a significant increase from the previous year’s 0.70 SEK.

The corrected record date for this dividend is now set for May 26, 2025. Shareholders will be pleased to know that the dividend payment is anticipated to take place shortly thereafter, specifically on May 30, 2025. This adjustment comes in light of a discrepancy highlighted in the year-end report for 2024, where the original record date was inaccurately stated.

Background on the Dividend Proposal

RaySearch Laboratories, known for its innovative contributions to the medical technology sector, has continually strived to reward its shareholders through consistent dividend payments. The proposed dividend of 3.00 SEK reflects the company's growth and financial health as it advances its mission to enhance cancer treatment through advanced software solutions.

The company's founder and CEO, Johan Löf, expressed his commitment to delivering value to shareholders. In his remarks, he stated, "We continuously aim to grow our company and provide our investors with reliable returns. The proposed dividend is a testament to our progress over the past year."

Importance of the Correction

The revision of the record date signifies RaySearch's dedication to transparency and accuracy in its communications with shareholders. Such corrections play a critical role in ensuring that investors are well-informed and can make strategic decisions based on accurate data. Investors are encouraged to keep track of these dates to effectively manage their stockholdings.

Next Steps for Shareholders

As the confirmed record date approaches, shareholders of RaySearch Laboratories should prepare for the upcoming dividend payout. It's advisable to consult with financial advisors or brokerage platforms for any necessary arrangements related to their shares.

Contact Information for Further Inquiries

For more specifics or any inquiries regarding the dividend or financial performance, investors can get in touch with Johan Löf at the company. He can be reached at +46 (0) 8 510 530 00 or via email at [email protected] This means that shareholders have a direct line to corporate representatives for clarifications, fostering an open and constructive relationship between the company and its investors.

In conclusion, as RaySearch Laboratories sets a new record date for the dividend, it reflects not only the company's growth trajectory but also its commitment to ensuring that shareholders are kept in the loop. With expectations high for 2025, the upcoming dividend represents a significant moment for the company and its investors alike.